Infensa CEO Mark Smythe received the LSQ McCullough Robertson Industry Excellence Award from Life Sciences Queensland in recognition of his major contributions to the Queensland life sciences industry

Written By Bronwyn Adams
Bronwyn Adams
Previous

Infensa scientists publish in European Heart Journal showing efficacy of lead drug candidate when administered at relevant timepoints in preclinical models of moderate and severe myocardial infarction
Next

Infensa CSO and co-founder Professor Glenn King received the Prime Minster’s Prize for Innovation, the highest honour for science translation in Australia